Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7252515rdf:typepubmed:Citationlld:pubmed
pubmed-article:7252515lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C0205494lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C0035448lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:7252515lifeskim:mentionsumls-concept:C1708943lld:lifeskim
pubmed-article:7252515pubmed:issue1lld:pubmed
pubmed-article:7252515pubmed:dateCreated1981-9-25lld:pubmed
pubmed-article:7252515pubmed:abstractTextPaired serum and cerebrospinal fluid (CSF) specimens from 30 multiple sclerosis (MS) patients and 30 matched neurological control (NC) patients were quantitatively tested for IgM-class rheumatoid factor (RF). Significantly elevated RF levels were found in serum from 6 MS patients and 12 NC patients. Seven of the latter 12 patients had a diagnosis of recurrent head pain. RF was detected in CSF from 2 MS patients and 2 NC patients. In 3 of the 4 cases, this could be explained by blood-brain barrier damage or normal diffusion of RF into CSF. Intrathecal RF synthesis was found in the remaining MS patient. These results suggest that RF production may be related to underlying pathological mechanisms in at least some MS and NC patients. They also confirm that RF must be carefully accounted for in etiological studies designed to demonstrate pathogen-specific IgM antibodies in, for example, MS patients.lld:pubmed
pubmed-article:7252515pubmed:languageenglld:pubmed
pubmed-article:7252515pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7252515pubmed:citationSubsetIMlld:pubmed
pubmed-article:7252515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7252515pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7252515pubmed:statusMEDLINElld:pubmed
pubmed-article:7252515pubmed:monthJullld:pubmed
pubmed-article:7252515pubmed:issn0022-510Xlld:pubmed
pubmed-article:7252515pubmed:authorpubmed-author:SalmiAAlld:pubmed
pubmed-article:7252515pubmed:authorpubmed-author:ZiolaBBlld:pubmed
pubmed-article:7252515pubmed:authorpubmed-author:ReunanenMMlld:pubmed
pubmed-article:7252515pubmed:issnTypePrintlld:pubmed
pubmed-article:7252515pubmed:volume51lld:pubmed
pubmed-article:7252515pubmed:ownerNLMlld:pubmed
pubmed-article:7252515pubmed:authorsCompleteYlld:pubmed
pubmed-article:7252515pubmed:pagination101-9lld:pubmed
pubmed-article:7252515pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:meshHeadingpubmed-meshheading:7252515-...lld:pubmed
pubmed-article:7252515pubmed:year1981lld:pubmed
pubmed-article:7252515pubmed:articleTitleIgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients.lld:pubmed
pubmed-article:7252515pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7252515pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7252515lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7252515lld:pubmed